| In millions, except per share items | Jun-30-22 | Mar-31-22 | Dec-31-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-K |
| Cash Flows from Operating Activities: | | | | | | |
| Net loss | 0.0 | -0.2 | -0.5 | 0.0 | 0.0 | 0.0 |
| Adjustments to reconcile net loss to net cash used in operating activities: | | | | | | |
| Interest earned on marketable securities held in Trust Account | -0.4 | 0.0 | 0.0 | | | |
| Unrealized gain on marketable securities held in Trust Account | 0.1 | 0.0 | 0.0 | | | |
| Changes in operating assets and liabilities: | | | | | | |
| Prepaid expenses | 0.1 | 0.1 | | | | |
| Accrued expenses | 0.1 | -0.1 | 0.2 | | 0.0 | 0.0 |
| Income taxes payable | | | | | | |
| Net cash used in operating activities | -0.1 | -0.3 | -0.1 | 0.0 | 0.0 | |
| |
| Cash Flows from Financing Activities: | | | | | | |
| Proceeds from promissory note – related party | | | | 0.0 | 0.1 | |
| Payment of offering costs | | | | 0.0 | -0.1 | |
| Net cash provided by financing activities | | 0.5 | | 0.0 | 0.0 | |
| Net Change in Cash | -0.1 | -0.3 | | 0.0 | 0.0 | |
| |
| Supplemental disclosure of non-cash investing and financing activities: | | | | | | |
| Offering costs included in accrued offering costs | | | | 0.0 | 0.0 | |
| Issuance of representative shares | | | | | | |
| Accretion for common stock to redemption amount | 0.1 | | | | | |